FDA-cleared profile

Infinitt PACS 7.0

Infinitt Healthcare Co.,Ltd. · Radiological images; modality varies or is not specified in FDA list · FDA-cleared (510(k))

A multi-modality PACS for viewing, sharing, processing, and displaying medical imaging studies; it is not diagnostic AI assistance.

Clinical role
Image management, viewing, communication, and 3D visualization with physician interpretation and human intervention.
Images and patients
Radiological images; modality varies or is not specified in FDA list · Multi-region; anatomy varies with the imported radiological study.
Key limitation
The system is not diagnostic assistance, and the physician solely determines diagnosis or treatment. Lossy-compressed mammography and digitized film-screen images are not for primary interpretation.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?It receives, stores, communicates, processes, and displays medical images and data across a PACS and networked review environment.
  • Which images are in scope?It handles multi-region medical images and data from various imaging sources, including DICOM 3.x studies, rather than one specific imaging task.
  • Who uses it?Trained professionals, including physicians, radiologists, nurses, and medical technicians, use it for image management and review.
  • What does the software produce?It stores, displays, communicates, processes, and prints studies, with functions such as multiplanar reconstruction, volume rendering, maximum-intensity projection, fusion, exports, and reports.
  • What is its most important limitation?It provides no diagnostic assistance: the physician alone determines diagnosis or treatment. Specific mammography input and display restrictions also apply.

Clinical takeaway. Infinitt PACS 7.0 is an image-management and visualization platform, not a diagnostic AI tool. Clinicians remain solely responsible for diagnostic and treatment decisions.

Evidence takeaway. The FDA package reports factory testing of the complete system configuration. It does not disclose clinical sensitivity, specificity, AUC, or other diagnostic-performance results because the cleared role is image management rather than diagnostic assistance.

Additional limitations
  • The FDA package describes a Windows DICOM view station with network and remote-server review, but does not establish the current local security posture, retention, training, pricing, or reimbursement.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
PACS software receives, stores, communicates, processes, and displays medical images and data within the system or across networks; it is not diagnostic assistance.
  • Exact FDA submission
  • Checked 2026-09-09
Workflow role
Image management, viewing, communication, and 3D visualization with physician interpretation and human intervention.
  • Exact FDA submission
  • Checked 2026-09-09
Required input
Medical images and data from various imaging sources, including DICOM 3.x; mammography primary interpretation is limited to preprocessed DICOM presentation images.
  • Exact FDA submission
  • Checked 2026-09-09
Output and clinician action
Stored, communicated, processed, displayed, and printed images and studies, including MPR, volume rendering, MIP, fusion, DICOM/general-format exports, and reports.
  • Exact FDA submission
  • Checked 2026-09-09
Care setting
Distributed radiology/PACS review environment with networked or remote-server studies; the FDA packet does not specify a facility type.
  • Exact FDA submission
  • Checked 2026-09-09
Intended users
Trained professionals, including physicians, radiologists, nurses, and medical technicians.
  • Exact FDA submission
  • Checked 2026-09-09
Limitations
The software provides no diagnostic assistance and the physician solely determines diagnosis or treatment. Lossy-compressed mammography and digitized film-screen images must not be used for primary interpretation; mammography requires a monitor meeting FDA specifications.
  • Exact FDA submission
  • Checked 2026-09-09
Evidence summary
Factory testing of the complete system configuration passed predetermined criteria without significant failures or safety/efficacy-impacting errors. No clinical sensitivity, specificity, AUC, or diagnostic-performance endpoint is disclosed.
  • Exact FDA submission
  • Checked 2026-09-09

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
Factory testing of the complete system configuration passed predetermined criteria without significant failures or safety/efficacy-impacting errors. No clinical sensitivity, specificity, AUC, or diagnostic-performance endpoint is disclosed.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-09
Reported sensitivity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

Reported specificity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K172803. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-09
Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not verified: Pricing information is recorded but not verified against a resolving source.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Medical images and data from various imaging sources, including DICOM 3.x; mammography primary interpretation is limited to preprocessed DICOM presentation images.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-09 · FDA K172803: Infinitt PACS 7.0

  2. Routing

    Source context, not route validation: Web-based Windows 7/8.1/10 DICOM view station integral to the INFINITT PACS/RIS solution; supports DICOM storage/query-retrieve, TLS, network deployment, and remote-server review.

    Scope: Exact FDA submission.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-09 · FDA K172803: Infinitt PACS 7.0

  3. AI processing

    Source context, not route validation: The exact FDA package describes Infinitt PACS 7.0 as a web-based, 3D-enabled DICOM view station running on Windows 7/8.1/10, deployed through a network, with web features for reviewing studies located on a remote server. Current hosting, data flow, and commercial configuration require vendor confirmation.

    Scope: Exact FDA submission. Packet wording: "Infinitt PACS 7.0 is a web-based, 3D-enabled DICOM view station running on Windows 7/8.1/10." … "This is made possible because Infinitt PACS 7.0 is deployed through a network and supports hanging protocol.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-11-14 · FDA K172803: Infinitt PACS 7.0

  4. Returned objects

    Source context, not route validation: Stored, communicated, processed, displayed, and printed images and studies, including MPR, volume rendering, MIP, fusion, DICOM/general-format exports, and reports.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-09 · FDA K172803: Infinitt PACS 7.0

  5. Viewer/worklist/report

    Unresolved route: Stored, communicated, processed, displayed, and printed images and studies, including MPR, volume rendering, MIP, fusion, DICOM/general-format exports, and reports.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-09 · FDA K172803: Infinitt PACS 7.0

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
The exact FDA package describes Infinitt PACS 7.0 as a web-based, 3D-enabled DICOM view station running on Windows 7/8.1/10, deployed through a network, with web features for reviewing studies located on a remote server. Current hosting, data flow, and commercial configuration require vendor confirmation.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "Infinitt PACS 7.0 is a web-based, 3D-enabled DICOM view station running on Windows 7/8.1/10." … "This is made possible because Infinitt PACS 7.0 is deployed through a network and supports hanging protocol.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

Integration
Web-based Windows 7/8.1/10 DICOM view station integral to the INFINITT PACS/RIS solution; supports DICOM storage/query-retrieve, TLS, network deployment, and remote-server review.
  • Exact FDA submission
  • Checked 2026-09-09

ACR exact-submission catalog context

ACR AI Central provides an exact-submission model card for Infinitt PACS 7.0; FDA labeling remains controlling for clinical use, limitations, and performance.

exact submission · checked 2026-09-09
Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K172803
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
Radiological images; modality varies or is not specified in FDA list
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-09
Anatomy
Multi-region; anatomy varies with the imported radiological study.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-09
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2017-10-27
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Exact FDA record reviewedStatus
2026-09-09Last searched
17Fields reviewed
9Source classes checked
0Awaiting review PubMed leads
0Awaiting review trial leads
0Unreviewed FDA recall leads

Exact-submission ACR model-card fields were normalized under the current provenance rules; vendor and independent-study confirmation remain distinct. Exact FDA scope controls clinical claims. ACR provides bounded exact-submission catalog context. Candidate literature metadata remains a discovery queue until full-text identity, endpoint, population, and version review is completed. Automated exact-name discovery found 0 PubMed and 0 ClinicalTrials.gov candidate records. Candidates require human product and version matching; zero candidates is not evidence that no studies exist. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads remain unpublished until a human confirms the exact product and tested version.

Source classes: fda ai list, fda decision summary, acr ai central product, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not verified - checked 2026-09-09 - Exact FDA submission

    No public price or quote for the exact K172803 configuration was established in this review.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-09-09 - Exact FDA submission

    No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Security: Not verified - checked 2026-09-09 - Exact FDA submission

    Exact-release security controls, data retention, hosting boundaries, and scoped assurance documentation require vendor confirmation.

  • Installation timeline: Not yet reviewed
  • Training: Not verified - checked 2026-09-09 - Exact FDA submission

    Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.

  • Monitoring: Not verified - checked 2026-09-09 - Exact FDA submission

    Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.

7 sources - 3 history items

Source ledger

  1. FDA K172803: Infinitt PACS 7.0

    U.S. Food and Drug Administration - Published 2017-10-27 - Accessed 2026-09-09

    Scope: identity, clinicalUse, modality, anatomy, workflow, evidence, implementation, deployment

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. Infinitt PACS 7.0 model card (K172803)

    American College of Radiology - Published 2026-06-26 - Accessed 2026-09-01

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. openFDA exact recall query for K172803

    U.S. Food and Drug Administration - Accessed 2026-09-09

    Scope: postmarketSafety

Research history

  1. K172803 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    fda record reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K252708

Relu Cloud

Relu BV

Authorized purpose: Relu Cloud manages, transfers, analyzes, displays, enhances, and stores oral and maxillofacial images and provides design input for dental solutions.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Oral and maxillofacial anatomy
Decision
2026-04-10
FDA-cleared K250237

InferOperate Suite

Beijing Infervision Healthcare Medical Technology Co., Ltd.

Authorized purpose: InferOperate Suite supports trained healthcare professionals in reading, interpreting, reporting, and treatment planning from medical images, with the submission's machine-learning functions applied to adult chest, abdomen, and pelvis CT.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Chest; abdomen; pelvis; and general patient anatomy represented in supported images
Decision
2025-09-15
FDA-cleared K250005

Clever One

Ewoosoft Co., Ltd

Authorized purpose: Clever One is dental imaging software for trained professionals to view and interpret DICOM images from CT, panoramic, cephalometric, intraoral, and other imaging equipment, with two-dimensional analysis and three-dimensional visualization tools.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Dental and craniomaxillofacial anatomy
Decision
2025-05-23

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history